the Life Sciences
Fluicell aims to be a world-leading provider of high resolution SINGLE-CELL DISCOVERY PLATFORMS for biomedicine, drug development, and bioprinting.
We redefine the approach to cell biology, and drug discovery by providing cost-effective platforms which generate unique and critical data from individual cells. Fluicell’s technologies are environmentally friendly and sustainable, which ultimately reduces cost and resource consumption.
BIOPEN | LOCALIZED SOLUTION DELIVERY FOR SINGLE-CELLS
Unique and smart platform to interrogate one or a small numbers of cells in complex environments.Read More
DYNAFLOW RESOLVE | SECONDARY ION CHANNEL SCREENING PLATFORM
State-of-the-art safety pharmacology screening.Read More
BIOPIXLAR™ RETINA | NEXT GENERATION 2D/3D BIOPRINTER
Product under development.Coming Soon
|25-28 March 2018||Monitoring Molecules in Neuroscience|
|07-11 July 2018||Fens 2018||Berlin, Booth #84|
|14-16 September 2018||Europhysiology 2018||London, Booth #19|
|30 Sept. to 03 Oct. 2018||SPS 2018||Washington DC, Booth #302|
|07-11 February 2019||BPS 2019||Baltimore, Booth #318|